Insurances & Business

India’s Ranbaxy Falls Nearly 7 Percent After Lipitor Deal

Investment | Sources: bnet.com

Similar/Related/News:

• Daiichi to Pay Up to $4.6 Billion For Control of Ranbaxy
TOKYO/NEW DELHI (Reuters) - Japanese drug maker Daiichi Sankyo Co Ltd <4568.T> moved to take majority control of India's biggest drug maker ...
• Pfizer May Make Counter Bid For Ranbaxy: Report
MUMBAI (Reuters) - Pfizer Inc <PFE.N> may bid for Ranbaxy Laboratories Ltd <RANB.BO>, countering a $4.6 billion offer by Japan's Daiic...
• Ranbaxy May Use M&A to Grow in Japan Generics Market
TOKYO (Reuters) - India's Ranbaxy Laboratories Ltd <RANB.BO> sees tremendous opportunities for growth in Japan's generics drug market and me...
• Spielberg and Dreamworks in Talks With India’s Reliance: Report
NEW YORK (Reuters) - Movie studio DreamWorks SKG is close to a deal with India's Reliance ADA Group to form a new movie venture, the Wall Street J...
• McGraw-Hill Profit Falls 44 Percent
NEW YORK (Reuters) - McGraw-Hill Cos Inc <MHP.N> said on Tuesday quarterly earnings fell 44 percent as business dropped at its Standard &...
• Consol Energy 1Q profit falls 34 percent (AP)
Coal miner Consol Energy Inc. said Thursday its first-quarter profit fell 34 percent, hurt by the shutdown of a mine whose roof collapsed, charges rel...
• Employers cut fewer jobs in April, jobless rate falls to 5 percent
WASHINGTON - Employers cut far fewer jobs in April than in recent months and the unemployment rate dropped to 5 percent, a better-than-expected showin...
• Blockbuster Shares Rise Over Talk of Deal Bust
LOS ANGELES (Reuters) - Shares of Blockbuster Inc <BBI.N> rose nearly 13 percent on what one analyst said was investor speculation that the ...